Exploratory clinical trial of dialysis dose monitor with optical measurement

Exploratory clinical trial of dialysis dose monitor with optical measurement - Exploratory clinical trial of dialysis dose monitor with optical measurement

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000011082

Enrollment

Registered

2013-08-01

Start date

2013-08-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

End stage renal disease

Interventions

Dialysis therapy for a week using dialysis machine equipped with the dialysis dose monitor newly developed by Nikkiso Co., Ltd.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Stable regular dialysis patients without malnutrition, severe anemia, unstable blood pressure who gives written consent by his/her free will to the participation to the study after receiving sufficient explanation.

Exclusion criteria

Exclusion criteria: Severe hypertension over systolic pressure of 120 mmHg Significant recirculation of blood access Pregnat patients, suspected of being pregnant or lactating patients.

Design outcomes

Primary

Measure	Time frame
Correlation with urea concentration of dialysis effluent and blood by the dialysis dose monitor	—

Countries

Japan

Contacts

Public ContactIsimori Isamu

Tokyo Women's Medical University Department of Blood Purification

ishimori@kc.twmu.ac.jp03-3353-8111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026